Antibody drug conjugates coming to primetime and new agents for breast cancer

Pancreatic, hepatic and biliary malignancies

Intervention of osteoclastogenesis that occurs in breast cancer and multiple myeloma

Updates on triple negative breast cancer and immunotherapy

Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer

A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM

Patient expectations and shared decision making in aRCC

Dr Enrique Soto Pérez de Celis, new Editor-in-Chief ecancermedicalscience

Importance of MRD in newly developed multiple myeloma

Cancer advocacy and fundraising in Nigeria

ASCO 2024: Highlights and analysis

ASCO 2024: Two studies report on isatuximab combos in transplant-ineligible patients with newly diagnosed multiple myeloma